Zymergen is a science and material innovation company rethinking biology and reimagining the world. A World Economic Forum Tech Pioneer, the company partners with nature to create never-before imagined materials and products across industries – from agriculture to electronics, consumer care to pharmaceuticals, and more. The company creates sustainable materials that are in use today, delivering value for Fortune 1000 companies with over $1 billion worth of products using Zymergen microbial innovations sold to date.
6 Reviews
Amazing work culture and supportive colleagues. Inclusive environment in tech dept
The goals were quite ambitious but the execution was poor.
Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that Ginkgo has completed its previously announced acquisition of Zymergen. The acquisition is expected to significantly enhance Ginkgo’s platform by integrating strong autom…
Item 2.01 Completion of Acquisition or Disposal of Assets. On October 19, 2022, Ginkgo Bioworks Holdings, Inc. a Delaware corporation , completed the previously announced acquisition contemplated by... | October 19, 2022
